title: Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness.
authors.forename: M
authors.initials: M
authors.lastname: Tischkowitz
authors.forename: A
authors.initials: A
authors.lastname: Gologan
authors.forename: H
authors.initials: H
authors.lastname: Srolovitz
authors.forename: M
authors.initials: M
authors.lastname: Khanna
authors.forename: W D
authors.initials: WD
authors.lastname: Foulkes
mesh_terms: D001005:Anus Neoplasms / Q000235:genetics*; D024682:BRCA2 Protein / Q000235:genetics; D002294:Carcinoma, Squamous Cell / Q000235:genetics*; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D007636:Keratoacanthoma / Q000235:genetics; D008297:Male; D051718:MutS Homolog 2 Protein / Q000235:genetics*; D009154:Mutation; D009378:Neoplasms, Multiple Primary / Q000235:genetics*; D016609:Neoplasms, Second Primary / Q000235:genetics*; D012626:Sebaceous Gland Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D012878:Skin Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D013577:Syndrome
chemical_list: D024682:BRCA2 Protein; C497172:MSH2 protein, human; D051718:MutS Homolog 2 Protein